The proportion of HLA-B*57 allele carriers in Ethiopian patients who developed anti-TB and ARV drugs induced liver toxicity (37.0%), particularly in those who developed cholestatic type of liver toxicity (44.8%) was significantly higher compared with those who tolerated the treatment (2.2%). The gene discussed is HLA-B; the disease is hepatotoxicity.